z-logo
open-access-imgOpen Access
Human β-cell Precursors Mature Into Functional Insulin-producing Cells in an Immunoisolation Device: Implications for Diabetes Cell Therapies
Author(s) -
Seunghee Lee,
Ergeng Hao,
Alexei Y. Savinov,
Ifat Geron,
Alex Y. Strongin,
Pamela ItkinAnsari
Publication year - 2009
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0b013e31819c86ea
Subject(s) - immunosuppression , islet , transplantation , progenitor cell , nod mice , medicine , nod , stem cell , diabetes mellitus , pancreatic islets , insulin , immunology , type 1 diabetes , biology , endocrinology , microbiology and biotechnology
Islet transplantation is limited by the need for chronic immunosuppression and the paucity of donor tissue. As new sources of human beta-cells are developed (e.g., stem cell-derived tissue), transplanting them in a durable device could obviate the need for immunosuppression, while also protecting the patient from any risk of tumorigenicity. Here, we studied (1) the survival and function of encapsulated human beta-cells and their progenitors and (2) the engraftment of encapsulated murine beta-cells in allo- and autoimmune settings.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom